It is estimated that about 2 billion people, especially those in lower- and middle-income countries, lack access to quality and affordable essential medicines. The situation is exacerbated by ...

WASHINGTON, July 17, 2025 /PRNewswire/ -- Axmed, a health technology venture revolutionizing access to medicines and health products through an innovative procurement platform, and Every Pregnancy, a ...

For too long, low- and middle-income countries (LMICs) have borne the brunt of global health disparities—accounting for over 80% of the world's population and more than 90% of its disease burden—yet ...

BASEL, Switzerland and NAIROBI, Kenya, Feb. 17, 2026 /PRNewswire/ -- Axmed, a health technology company headquartered in Switzerland with regional headquarters in Nairobi, Kenya, today announced it ...

The provision of affordable medicines to low- and middle-income countries is pitiful, leaving billions of people vulnerable to diseases that could be treated and often cured if they lived in a richer ...

Axmed Signs $7M Supply Agreement Under the Resiliency through Azithromycin for Children (REACH) Programme to Supply Up to 16 Million Doses of Quality-Assured Medicines in Burkina Faso ...

Geneva, May 21, 2025 (GLOBE NEWSWIRE) -- As part of the global health movement to expand affordable access to high-quality medicines, the Gates Foundation has awarded a $5 million grant to Axmed, a ...

BASEL, Switzerland, Dec. 18, 2025 /PRNewswire/ -- Postpartum haemorrhage (PPH), is the leading cause of maternal death in Sub-Saharan Africa. Standard care in these settings often relies on visual ...

Axmed’s B2B marketplace aggregates demand for critical medicines in underserved regions to improve the availability, affordability, and distribution of life-saving medicine while extending ...